← SynDRA
PF-03882845
SynDRA canonical compound SYN0023895 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NR3C2 |
|---|
| Mechanism of action | mineralocorticoid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- NR3C2 ANTAGONIST
- Mineralocorticoid receptor antagonist
- NR3C2 MODULATOR
Cross-references
Synonyms
- CHEMBL1215331
- PF-3882845
- PF3882845
- UNII-34ZKU73FU3
- 34ZKU73FU3
- (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid
- compound 2 [PMID: 24738581]
- SCHEMBL552307
- GTPL9061
- DTXSID70144940
- XNULRSOGWPFPBL-REWPJTCUSA-N
- (+/-)-(3SR,3aRS)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid
- BDBM50324210
- ZINC58583489
- DB11814
- NCGC00485023-01
- PF-03882845, >
- PF 3882845
- RefChem:172227
- DTXCID9067431
- PF03882845
- PF-03882845(PF03882845)
- orb1706807
- SCHEMBL29412449
- SCHEMBL29642523
- GLXC-07434
- AKOS040742404
- EBC-421063
- DA-76785
- HY-12738
- CS-0012315
- NS00072781
- H58677
- T16502
- PF-03882845, >=98% (HPLC)
Look up PF-03882845 in the interactive SynDRA portal →